Sensex

Thursday, July 28, 2011

Fw: Investor's Eye: Update - HUL, ITC, Sun Pharma, PNB, Corp Bank, Orient Paper, Glenmark Pharma

 

Sharekhan Investor's Eye
 
Investor's Eye
[July 28, 2011] 
Summary of Content
STOCK UPDATE
Hindustan Unilever     
Cluster: Apple Green
Recommendation: Hold
Price target: Under review
Current market price: Rs323
Upgraded to Hold
Result highlights
  • Hindustan Unilever Ltd (HUL)'s Q1FY2012 results are ahead of our expectation largely on account of a lower than expected advertisement and promotional expenditure, which aided the operating profit margin (OPM) to sustain at 12.3% on a year-on-year (Y-o-Y) basis (ahead of our expectation of 11% for the quarter).
  • Its net sales grew by 14.8% year on year (YoY) to Rs5,503.9 crore (in line with our expectation of Rs5,503.9 crore). The growth was driven by a mix of both sales volume growth and price increases undertaken to reduce the pressure on the margins. The sales volume growth in the domestic consumer business stood at 8.3% YoY (the growth moderated slightly from 13.0% Y-o-Y growth in Q4FY2011).
  • The key input prices stood significantly higher on a Y-o-Y basis (palm oil-32% YoY; LABfs-47% YoY; caustic soda [flakes]-34.2% YoY). Hence the gross margin declined by 482 basis points YoY to 44.1% during the quarter. However, pruning the advertisement spend helped HUL to maintain the operating profit margin (OPM) during the quarter. The advertisement spend as a percentage of sales stood at 11.5% in Q1FY2012 as against 15.7% in Q1FY2011.
  • Thus the operating profit grew by 13.4% YoY to Rs678.8 crore (ahead of our estimate of Rs603.2 crore) and the adjusted net profit grew by 12.4% YoY to Rs581.3 crore during the quarter (ahead of our estimate of Rs549.0 crore).
  • All the segments of the company posted a better performance in Q1FY2012. The HPC business grew by 15.4% YoY with the soap and detergent and personal segments registering a strong double-digit growth of 12.8% YoY (in line with our expectation of a 12.0% Y-o-Y growth) and a 19.3% Y-o-Y growth during the quarter. While the profit before interest and tax (PBIT) margin of the soap and detergent segment improved sequentially by 172 basis points to 9.2%; the PBIT margin of the personal wash segment was maintained at about 25% during the quarter. 
  • Also the food business registered a strong performance with the business revenues growing by a robust 14.9% YoY during the quarter. The revenues of the packaged food segment (including the processed foods and ice cream categories) and the beverage segment grew by 18.0% YoY and 13.1% YoY respectively during the quarter.
  • It was the seventh consecutive quarter of a volume-led growth for HUL with all the segments performing well during the quarter. Though the input cost pressure is likely to sustain for the next one to two quarters, the company's ability to maintain the double-digit top line growth (with a decent sales volume) gives us hope of a decent bottom line growth in FY2012. Hence we upgrade our recommendation on the stock from Reduce to Hold. However, we will revise our price target after fine-tuning our estimates after tomorrow's conference call. At the current market price the stock trades at 30.1x and 26.2x its FY2012E and FY2013E earnings.
 
ITC     
Cluster: Apple Green
Recommendation: Buy
Price target: Rs223
Current market price: Rs206
Q1FY2012 results: First-cut analysis
Result highlights
  • ITC's Q1FY2012 results are ahead of our estimates largely on account of a slightly higher than expected top line growth and a higher than expected other income during the quarter.
  • The net sales (including the other operating income) grew by 20.6% year on year (YoY) to Rs5,860.2 crore (ahead of our estimate of Rs5,669.7 crore) on the back of a strong performance by all the business verticals during the quarter. The operating profit margin (OPM) sustained at around 34.0% in Q1FY2012. Hence the operating profit grew by 20.2% YoY to Rs1,976.1 crore.
  • This along with a higher other income resulted in a 24.5% year-on-year (Y-o-Y) growth in the reported profit after tax (PAT) to Rs1,332.7 crore (ahead of our estimate of Rs1,260.7 crore) during the quarter.
  • The core cigarette business' revenue grew by about 13.0% YoY in Q1FY2012. The cigarettes sales volume growth must have stood at higher single digits during the quarter. The profit before interest and tax (PBIT) margin of the business improved to about 30.0% during the quarter.
  • It was yet another quarter of an excellent performance by the non-cigarette fast moving consumer goods (FMCG) business with its revenues growing by 19.4% YoY. The losses of business were down by 15% YoY.
  • The performances of the agri business and paper, paperboard and packaging businesses were the highlights of the quarter. The revenues of the agri business grew by about 27% YoY to Rs1,707.1 crore on the back of the strong sales of soy, wheat and coffee during the quarter. The profit before interest and tax (PBIT) margin of the agri business was maintained at 9.2% during the quarter. The revenues of paper, paperboard & packaging business grew by strong 22% YoY with the PBIT margin sustaining at 22.0% on the back of an improved product mix and better realisations.
  • Being a lean quarter the hotel business revenues grew by just 12.2% YoY to Rs252.5 crore. The PBIT margin of the business improved by 321bps YoY to 20.3% during the quarter
  • We will review our estimates for FY2012 and FY2013 after our interaction with the management of the company and shall come out with a detailed note on the results. We maintain our Buy recommendation on the stock with a price target of Rs223. At the current market price the stock trades at 26.2x and 22.2x its FY2012E and FY2013E earnings respectively. 
 
Sun Pharmaceutical Industries      
Cluster: Ugly Duckling
Recommendation: Buy
Price target: Rs534
Current market price: Rs518
Q1FY2012 results: First-cut analysis
Result highlights
  • Earnings ahead of Street estimates: Sun Pharmaceutical Industries (Sun) in its Q1FY2012 results posted an 11.2% de-growth in the net profit to Rs501 crore but the same was ahead of Street estimates. The net sales of the company grew by 19.8% year on year (YoY) to Rs1,635.7 crore. Since Taro Pharmaceutical Industries (Taro) became a subsidiary of Sun from September 20, 2010 the latter's performance for the current quarter includes the results of Taro and its subsidiaries and therefore is not comparable with the corresponding figures of the previous quarter.
  • Performance by geography: Indian branded generic sales grew by 18% YoY to Rs638 crore. The revenue growth of the company in the Indian generic market was supported by 7 new product launches. In the export market, US formulation which accounts for 37% of the total sales, posted revenue of $139 million whereas generic formulation in the rest of world (RoW) markets accounted for $56 million. 
  • Operating margins contracted by 11 percentage points YoY but improved QoQ: Sun reported a sharp contraction in its operating profit margin (OPM) by 11 percentage points to 33.5% on account of the high base effect and a sharp increase in the employee cost (up by 123% YoY). However on a sequential basis the OPM of the company improved by 315bps which is on account of a decrease in other expenditure by 13.3% and also due to a decrease of research and development (R&D) expenditure as a percentage of sales to 5.4% as against 6.2% in Q4FY2011. 
  • Healthy other income through receipt of interest: During the quarter the company booked healthy other income of Rs96.9 crore of which Rs31.5 crore is on account of net interest income. 
  • Performance of Taro: Taro reported a 14% YoY increase in its revenue to $112 million whereas net profit has come significantly higher at $36 million. 
  • Caraco became wholly owned subsidiary: Caraco has convened a shareholder meeting on June 14, 2011 and become a wholly owned subsidiary of Sun.
  • ANDA approvals for 7 new products have been received during Q1FY2012: During the quarter abbreviated new drug applications (ANDAs) for 6 products have been filed of which 4 products are by Sun and the remaining 2 by Taro. Cumulatively the company has filed ANDAs for 383 products. In terms of approvals the company has received ANDAs for 7 products in Q1FY2012 taking the total number of approvals to 232. Further the total number of patent applications submitted now stand at 551 with 250 patents granted so far. 
  • We expect Sun's strong domestic business, its niche US market (controlled release substances, hormones etc) and the improving visibility of its patent pipeline to drive a steady growth in the long term. With a strong cash balance, Sun is well positioned to capitalise on the growth opportunities. We shall come out with a detailed note post attending the conference call. We maintain our Buy recommendation on the stock with a price target of Rs534. At the current market price, the stock trades at 24.2x FY2012E earnings and 21.1x FY2013E earnings.
 
Punjab National Bank     
Cluster: Ugly Duckling
Recommendation: Buy
Price target: Rs1,410
Current market price: Rs1,103
Strong operating performance 
Result highlights
  • Punjab National Bank (PNB) reported a strong set of numbers for Q1FY2012 as net profits grew 3.4% year on year (YoY) to Rs1,105 crore despite making a one off provision of Rs389 crore (as per revised provisioning norms) and lower treasury profits. This was driven by a strong growth in net interest income (NII) which grew 19% YoY and 2.9% quarter on quarter (QoQ). The margins remained steady at 3.84% and showed a marginal decline of 7bps QoQ. The asset quality deteriorated as gross non performing assets (NPAs) increased to 2% compared to 1.79% in Q4FY2011. We estimate PNB's earnings to grow at a compounded annual growth rate (CAGR) of 19% over FY2011-13 led by a 22% CAGR growth in advances. We maintain our Buy rating with a price target of Rs1,410 (1.5x FY2013E book value [BV]).
  • Strong growth in NII: The NII increased by 19% YoY and ~3% QoQ , in line with our estimates. The growth in NII was driven by steady margins and a healthy growth in advances. During Q1FY2012 the advances growth remained flat on a sequential basis while it increased by 23.4% YoY driven by small and medium enterprise (SME; +36% YoY), retail (+24% YoY) and overseas advances (+77% YoY). We have assumed an advances growth of 22% CAGR over FY2011-13.
  • Margins remain firm, on higher yields: Unlike other public sector unit (PSU) banks, PNB's net interest margin reported a marginal decline of 7bps QoQ to 3.84%. This was driven by a 55bps QoQ increase in yields on advances to 11.4% which offset the 64bps increase in the cost of deposits. The reported yield on investment also went up by 55bps QoQ due to shifting of investments towards longer dated securities. Due to rising cost pressures and shifting to higher rated advances the bank expects to maintain its net interest margin (NIM) at ~3.5% levels.
  • Strong growth in fee income: The overall non interest income increased by 24.3% YoY despite lower treasury profits (Rs48 crore vs Rs121 crore in Q1FY2011). This was on account of a strong growth in fee income and higher recovery from written off accounts (Rs109 crore vs Rs76 crore in Q1FY2011). The core fee income growth during the quarter was 25% YoY and 6% QoQ.
  • Asset quality disappoints: The gross NPAs and net NPAs increased to 2% and 0.88% respectively compared to 1.79% and 0.85% in Q4FY2011. The bank reported slippages of Rs1,177 crore (~2% annualised) while recoveries were to the tune of Rs663 crore. The bank made Rs389 crore of one off provisions (Rs243 crore for NPAs and Rs146 crore for standard advances) based on revised Income Recognition Asset Classification (IRAC) norms. During the quarter Rs512 crore of advances were restructured while outstanding restructured loans were ~6.3% of advances. The bank maintained its guidance to hold NPAs at around 2% levels. 
  • Opex increases QoQ due to pension provisions: The employee expenses surged sequentially (despite a high base) by 7% mainly contributed by the pension provisions of Rs260 crore (excluding Rs166 crore on second pension liability). Consequently, the cost to income ratio increased to 41.8% from 39.9% in Q4FY2011.
  • Plans to acquire 30% stake in MetLife: The bank has finalised Metlife as its insurance partner and will acquire a 30% stake in the company. The bank is likely to acquire a stake via issue of fresh equity shares in the insurance company. According to the management the capital infusion in MetLife is largely over and it would help the bank in increasing its fee income.
  • Valuations: PNB delivered a superior performance in Q1FY2012 led by healthy core performance. The margins remained steady despite pressures while fee income showed strong growth. In view of slower credit volumes, likely compression in margins and higher credit cost we have slightly trimmed our FY2012 and FY2013 estimates. We expect PNB's earnings to grow at a CAGR of 19% over FY2011-13, leading to a return on equity (RoE) of around 22%. We maintain our Buy rating with a price target of Rs1,410.
 
Corporation Bank     
Cluster: Apple Green
Recommendation: Buy
Price target: Rs690
Current market price: Rs514
Price target revised to Rs690
Result highlights
  • Corporation Bank in Q1FY2012 reported a net profit of Rs351.4 crore, a growth of 5.3% year on year (YoY), which is higher than our estimates. During the quarter there was a write back of tax provision amounting to Rs63.3 crore which aided profit growth. Excluding the one-time gain of tax reversal, the earnings of the bank declined by 13.7% YoY and 16.2% quarter on quarter (QoQ) to Rs288 crore. The net interest income (NII) of the bank was short of our estimates as it remained flat on a year-on-year (Y-o-Y) basis and declined sequentially by 7.1% led by a sequential decline in advances and margins (margins stood at 2.1% for the quarter compared to 2.48% in Q4FY2011). The asset quality of the bank also deteriorated as gross and net non performing assets (NPAs) increased to 1.07% and 0.52% respectively compared to 0.91% and 0.46% in Q4FY2011. We have reduced our estimates for FY2012 & FY2013 and revised the price target to Rs690 from Rs720 earlier . We maintain our BUY rating on the stock.
  • NII growth remains flat on Y-o-Y basis: The NII of the bank remained flat on a Y-o-Y basis and declined by 7.1% QoQ to Rs707.5 crore. This was on account of a sequential dip in advances and a contraction in margins. The advances of the bank grew by 21.8% YoY while they declined by 9.1% sequentially. Deposits of the bank increased by 29.4% YoY and increased marginally by 1% QoQ. Consequently the credit to deposit ratio of the bank declined to 67% in Q1FY2012 from 74.4% in Q4FY2011.
  • NIM contracts 38bps sequentially; CASA ratio slips to 21%: The margins of the bank came off sharply by 38bps QoQ to 2.1%. This was led by a sharp increase in the cost of deposits of the bank which grew by 87bps sequentially to 7.27%. The current account-savings account (CASA) of the bank also declined sharply to 21% from 26% in the earlier quarter leading to a sharp jump in the cost of deposits.
  • Subdued growth in non-interest income: The non -interest income of the bank increased by 8.9% YoY mainly on account of a decline in treasury profits (Rs34.3 crore vs Rs53.8 crore in Q1FY2011) and lower recoveries from written off accounts (Rs39 crore vs Rs59.2 crore in Q1FY2011). The core fee income showed a growth of 12% YoY. 
  • Lower NPA provisions and write back of tax supported bottom line: The provision expenses for the quarter were reduced to Rs167 crore as against Rs270 crore in Q4FY2011. This was mainly due to lower provisions for NPAs at Rs90 crore during the quarter as against Rs187 crore during the previous quarter. Of the provisions for NPAs of Rs90 crore, Rs35 crore are on account of one time provision as per new Income Recognition Asset Classification (IRAC) guidelines. Provisions on investments were at Rs70.6 crore during the quarter.
  • Asset quality deteriorates: The asset quality of the bank deteriorated during the quarter as gross NPAs increased sequentially to 1.07% (from 0.91%) while net NPAs increased to 0.52%. The slippages during the quarter were Rs154.8 crore (~1% annualized). The provision coverage ratio of the bank stood at 74.90% in line with that of the preceding quarter. 
  • Tax write back led to reduction in tax rate: The tax/ profit before tax (PBT) ratio of the bank during the quarter declined to 14.1% as against 27.7% in Q4FY2011. This was majorly due to the one time write back of tax provision of Rs63.3 crore during the quarter. 
  • Outlook: Corporation Bank's Q1FY2012 numbers were qualitatively weak as tax write back and lower provisions aided growth in profits. The bank's margins and CASA ratio have slipped to much lower levels compared to its peer banks. We have reduced our estimates for FY2012 and FY2013 by 7% and 3% respectively. We have also revised our target price downwards to Rs690 (1.05x FY2012E book value [BV]). Currently the stock is trading at 0.8x FY2013E BV. We maintain our Buy recommendation on the stock.
 
Orient Paper and Industries     
Cluster: Vulture's Pick
Recommendation: Buy
Price target: Rs70
Current market price: Rs60
Demerger of cement business to unlock value
Result highlights
  • Impressive performance, earnings in line with estimate: For Q1FY2012 Orient Paper & Industries Ltd (OPIL) has posted a net profit of Rs59.4 crore (improved by 73.4% year on year [YoY]), which is in line with our estimate. The impressive performance was driven mainly by a surge in the average blended realisation of 30.6% YoY and of 6.6% on a sequential basis. However, the paper division continued its disappointing performance during the quarter with a loss at the earnings before interest and tax (EBIT) level.
  • Cement and electrical divisions drive overall revenue growth: The net sales of the company grew by 20.9% YoY to Rs533.9 crore. The top line growth was driven by the electrical division (which grew by 22.3% YoY) and the cement division (which grew by 11.4% YoY). Despite a 14.7% year-on-year (Y-o-Y) decline in the volume the cement division's revenue growth was supported by a sharp increase in the realisation (up 30.6% YoY). The demand environment in one of its key markets continues to be sluggish and hence the volume growth in the coming two quarters will remain under pressure. 
  • Margin expanded in spite of overall cost inflation and loss in paper business: On the margin front the operating profit margin (OPM) expanded by 312 basis points YoY to 19.4%. The increased profitability of the cement division due to the increase in the realisation largely offset the cost pressure and the loss in the paper division. Further, the profitability of the electrical division also improved marginally which added to the overall OPM. Consequently, the operating profit increased by 44.1% YoY to Rs103.5 crore. 
  • Other income boosted through sale of CER: The other income during the quarter increased by 65.5% YoY to Rs14.5 crore, which was supported by Rs8.5 crore received on account of CER sale. 
  • Approved demerger of cement business into separate entity, which will get listed: The board of directors of the company has decided to demerge the cement undertaking of the company by transferring the same to a newly formed wholly owned subsidiary, Orient Cement. The shareholder of OPIL will get one new equity share of Orient Cement for each share held in OPIL. Further, Orient Cement is proposed to be listed on the BSE and NSE, and the appointed date for the scheme is April 2012. We believe the development is a positive move for the company as it will unlock the value for the shareholder through direct exposure to a pure cement player. 
  • Huge outstanding water tax, company applied for waiver as per agreement: As per the auditor's report, no provision against the water tax amounting to Rs181.7 crore has been made by the company since the company's application for waiver thereof is under consideration by the state government of Madhya Pradesh.
  • Planning to introduce new range of products in electrical division: The board of directors of the company has decided to further diversify the range of its consumer electrical products by adding household appliances such as mixers, geysers, coolers and room heaters in addition to fans and lighting products. Initially the company will do trading of aforesaid new products and the activity is expected to start from Q3FY2012.
  • Maintain Buy with price target of Rs70: Due to the supply discipline mechanism followed by the manufacturers in the southern region, the company is benefited in terms of a strong growth in the realisation but going ahead we believe cement prices would come under pressure with a likely increase in the supply. However, the company's efficient cost structure gives it an advantage over the other players. Further, the company is in the process of introducing a new range of products in the electrical division which could lead to a strong revenue growth in the electrical division. Further, in addition to a strong balance sheet and attractive valuation, the demerger of the cement division will act as a re-rating trigger for the stock. Hence, we maintain our Buy recommendation on the stock with a price target of Rs70. At the current market price the stock trades at a PE of 5.8x and EV/ EBIDTA of 3.8x, discounting its FY2012 earnings estimates.
 
Glenmark Pharmaceuticals     
Cluster: Apple Green
Recommendation: Buy
Price target: Rs426
Current market price: Rs331
Price target revised to Rs426
Result highlights
  • Earnings growth ahead of Street's estimate: Glenmark Pharmaceuticals (Glenmark) reported a strong growth (of 23.1% year on year [YoY]) in its net profit on a consolidated basis and stood at Rs210 crore, which is ahead of the Street's estimate. The higher than expected earnings growth was largely driven by a better than expected revenue growth in some key geographies and margin expansion.
  • Revenue grew by 27.8% supported by rebound in the US generic business and formulation business in the Indian market: The revenue of the company (excluding out-licencing fees) grew by 27.8% to Rs757 crore. The specialty business division, which accounts for 55% of the total revenue, reported a 29% growth. Geographically, the Indian market witnessed a 20% growth due to the launch of two new products, named Vorth TP and Doriglen. The Latin American market registered a 62% growth, which was supported by the launch of nine new products across the region. On the other hand, the generic business, which forms 45% of the total revenue, also supported the overall revenue growth. Geographically, the US market rebounded with a revenue growth of 37% whereas from the European market the company booked revenue of Rs17.5 crore (a growth of 118% YoY). In addition the company has also booked out-licencing fees to the tune of Rs111.2 crore as compared to Rs89.5 crore in the corresponding quarter of the previous year. 
  • OPM expanded due to a decrease in material cost and increase in out-licencing fees: The operating profit margin (OPM) of the company increased by 53 basis points YoY to 34.2% on account of a decrease in the material cost as a percentage of sales and increase in the out-licencing fees by 24%. However, adjusting for the out-licencing fees, the OPM for the quarter stood at 24.5%, which is ahead of the management guidance of 22-23%. However, the management has maintained its earlier OPM guidance of 22-23%. 
  • ANDA approval received for 4 new products: During the quarter the company received the final abbreviated new drug application (ANDA) approval for four products and filed three ANDAs with the US Food and Drug Administration (USFDA). In the forthcoming quarter the company plans to file four new products and anticipates the launch of seven new products. At the end of Q1FY2012, the company had a portfolio of 69 generic products authorised for distribution in the US market as well as 40 ANDAs in various stages of approval process with the USFDA.
  • Glenmark has received $15 million from Salix Pharmaceuticals, Inc, USA (Salix). This is as per an agreement for advance against the commitment fee, which is to cover the risks associated with the upgradation of its manufacturing facilities to meet the anticipated increased requirements of Salix for Crofelemer, which is for multiple diarrhoeal conditions. Through an agreement between the two companies, Salix agreed to pay Glenmark a $21.6-million commitment fee in five equal annual installments, with the first annual installment in July 2012. The commitment fee is in addition to the compound purchase price payable by Salix to Glenmark.
  • Upgrading earnings estimates for FY2012 and FY2013: We are upgrading our earnings estimates for FY2012 and FY2013 mainly to incorporate the higher than expected revenue growth particularly from the geographies like the USA, India and Latin America. We believe new product launches and ability to maintain the market share of the existing products will help sustain the momentum in the revenue growth. The revised earnings per share (EPS) estimates for FY2012 and FY2013 now stand at Rs24.1 and Rs22.6 respectively.
  • Maintain Buy with revised price target of Rs426: Given the expectation of a healthy performance by the core business and a favourable risk-reward ratio, we maintain our Buy recommendation on the stock with a revised price target of Rs426 (15x FY2012E core earnings for the base business and Rs64 for research and development [R&D]). At the current market price, the stock trades at 13.8x FY2012E earnings and 14.7x FY2013E earnings.   

 
Click here to read report: Investor's Eye

     
Regards,
The Sharekhan Research Team
myaccount@sharekhan.com 
 www.sharekhan.com to manage your newsletter subscriptions
 


Fw: IIFL- IPO Note: L&T Finance Holdings Ltd (L&TFH) – Subscribe

 

L&T Finance Holdings Ltd (L&TFH) – Subscribe
Price band Rs51-59
 
Diversified loan book; growth has been strong in the recent past
L&TFH through its subsidiaries L&T Finance and L&T Infra Finance offers a broad spectrum of financial products and services. The consolidated loan book of the company could be broken into infrastructure finance (40%), retail finance (37%), corporate finance (20%) and others (3%). Over the past two years, the consolidated loan book has witnessed 57% CAGR. More importantly, the book has become more diversified with the share of retail and corporate finance segments combined having declined from 69% in FY09 to 58% in FY11.
 
Wide pan-India presence; exploring opportunities to leverage it
As of May 2011, L&TFH had 837 points-of-presence spread across 23 states thereby enabling the company to cater to a large customer base (especially in rural and semi-urban areas). Company further plans to strengthen its reach through expansion in areas offering significant opportunities to increase revenue and giving competitive advantage. Such an extensive distribution network would be leveraged by the company to provide new products and services and also foray into new business segments. With an edge over competition in terms of reach, robust loan growth momentum is likely to continue.
 
Sanguine asset quality; however, some slippages may crop up              
Across segments, L&TFH's asset quality has improved substantially in FY11 despite the robust growth registered over the past few years. For L&T Finance (comprising retail and corporate finance business), the Gross and Net NPAs stood at 1.4% and 0.8% respectively at end-FY11. In L&T Infra Finance, the Gross and Net NPAs stood at 0.7% and 0.5% respectively at end-FY11. More importantly, about 71%, 91% and 90% of the Corporate, Retail and Infra segment advances are secured thereby providing high level of comfort. However, given the current challenging credit environment, one could expect some slippage in NPL ratios.
 
Robust profitability reflected in high return ratios; 'Subscribe'                         
RoA and RoE have improved materially in the past two years for L&T Finance driven by significant expansion in NIM and improvement in asset quality. End-FY11, RoA of the company stood at 2.5%, remarkable in the light of the loan book mix. RoE was at 16% with the leverage at 5.3x. L&T Infra Finance's RoA has been stable at 3.5% in the past two years. This is better than IDFC (like-to-like competitor) which has been earning around 3%. Further, RoE is impressive at 18%. With valuation reasonable at mean 2.5x P/BV (pre-IPO) we recommend subscribing to the IPO.  
 
 
 

Tuesday, July 26, 2011

Fw: Investor's Eye: Pulse - Monetary policy review; Update - Glenmark, BHEL, Maruti Suzuki

 

Sharekhan Investor's Eye
 
Investor's Eye
[July 26, 2011] 
Summary of Content
PULSE TRACK
  • Monetary policy review

STOCK UPDATE
Glenmark Pharmaceuticals     
Cluster: Apple Green
Recommendation: Buy
Price target: Rs376
Current market price: Rs338
Q1FY2012 results: First-cut analysis
Result highlights
  • Earnings growth ahead of street estimates: Glenmark Pharmaceutical (Glenmark) reported a strong growth (23.1% year on year [YoY]) in its net profit on a consolidated basis at Rs210 crore which is ahead of Street estimates. A higher than expected earnings growth has been largely driven by better than expected revenue growth in some key geographies and margin expansion.
  • Revenue grew by 27.8% supported by rebound in the US generic business & formulation business in the domestic market: The revenue of the company (excluding out-licensing fees) grew by 27.8% to Rs757 crore with the specialty business division which forms 55% of the total revenue reporting a 29% growth. In terms of geographies, the Indian market witnessed a 20% growth on the back of launch of two new products-Vorth TP and Doriglen while Latin America registered a 62% growth supported by 9 new product launches across the region. The generic business which forms 45% of the total revenue also supported the overall revenue growth. The US market rebounded with a revenue growth of 37% whereas the company booked a revenue of Rs17.5 crore (grew by 118% YoY) from the European market. In addition the company has also booked out-licensing fees to the tune of Rs111.2 crore as compared to Rs89.5 crore in the corresponding quarter previous year. 
  • Operating profit margin expanded due to decrease in material cost & increase in out-licensing fees: The operating profit margin of the company increased by 53bps YoY to 34.2% on account of a decrease in the material cost as a percentage of sales and increase in the out-licensing fees by 24%. However, adjusting for the out-licensing fees, the operating profit margin (OPM) for the quarter stood at 24.5% which is ahead of management guidance of 22-23%. However, the management has maintained its earlier guidance of 22-23% on the OPM. 
  • ANDA approval received for 4 new products: During the quarter the company has received final abbreviated new drug application (ANDA) approval for 4 products and filed 3 ANDAs with the US Food and Drug Administration (USFDA). In the forthcoming quarter the company plans to file 4 new products and anticipates launch of 7 new products. At the end of Q1FY2012, the company has a portfolio of 69 generic products authorised for distribution in the US market as well as 40 ANDAs in various stages of approval with the USFDA.
  • The company received $15 million from Salix Pharmaceuticals Inc, USA. This is as per an agreement for advance against commitment fee which is to cover Glenmark's risks associated with upgrading its manufacturing facilities to meet Salix's anticipated increased requirements in demand for Crofelemer which is for multiple diarrhoeal conditions. Through an agreement between the two companies, Salix agreed to pay Glenmark a $21.6 million commitment fee in five equal annual installments, with the first annual installment in July 2012. The commitment fee is in addition to the compound purchase price payable by Salix to Glenmark.
  • Given the healthy performance expectation on the core business and a favorable risk-reward ratio, we maintain our Buy recommendation on the stock with a price target of Rs376. We will shortly come out with a detailed note with likely upgrades in the earnings estimates for FY2012 and FY2013. At the current market price, the stock trades at 21.6x FY2012E earnings and 16x FY2013E earnings.
 
Bharat Heavy Electricals    
Cluster: Apple Green
Recommendation: Buy
Price target: Rs2,596 
Current market price: Rs1,909
Q1 results a one off, order inflows need to improve 
Result highlights
  • Q1FY2012 results-a mixed bag: Bharat Heavy Electricals Ltd (BHEL)'s Q1FY2012 results were a mixed bag with the revenue falling short of our expectation (caused by multiple one off events) and profit after tax (PAT) coming above our expectation. Despite significant margin pressure and lower revenue booking in the power business the net profit was higher due to a strong performance in the industry segment and a higher other income. However, low order booking is a concern as the book-bill ratio has further come down to 3.7x. 
  • Revenue growth disappointing due to one off events: The net income from the operations increased by merely 10% year on year (YoY) against our expectation of a 23.8% growth. This sluggishness was caused by a poor pick-up in the sales of its power segment on account of various reasons like delay in clearances at ports, lower pick up in delivery from customers etc. The industry division's revenue grew by 12% YoY (vs our expectation of a 10% growth). The company has indicated that revenue booking would pick up in the coming quarters and maintained its earlier Rs50,000 crore revenue booking target for FY2012.
  • Power system division's margin the lowest in 15 quarters: The company reported an operating profit margin (OPM) of 13.6%, which was higher than our expectation of 12%. Here, the effect of the rise in the raw material cost was balanced by an increase in the inventory. Other expenses increased on account of Rs114 crore provisioning for contractual obligations. Segment-wise, the power segment reported a fall in the profit before interest and tax (PBIT) margin to 16.5% from 19.8% in Q1FY2011 on low revenue booking. The industry segment reported a doubling of the PBIT margin to 22.6% on account of execution of good margin orders in the quarter.
  • Net profit rose by 22.1%: The other income jumped by 38.5%. Further, boosted by almost a nil interest charge and a lower tax rate, the adjusted net profit jumped by 22.1% YoY, which was above our estimate. 
  • Order inflow disappoints, book-to-bill ratio falls further: BHEL has reported a total order inflow of Rs2,714 crore for Q1FY2012 (down 74.9% YoY), finishing the quarter with a total order backlog of Rs1,596 crore (down 2.8% YoY). The book-bill ratio has further come down to 3.7x its FY2011 revenue, implying dire need for the order inflow to pick up in the coming quarters. The power segment order inflow was extremely weak due to multiple problems prevailing in the power sector like coal linkage issues and environmental clearances resulting in delay in finalisation of orders. However, the company maintained its 60,000 crore plus of order inflow target for FY2012 based on expected orders from state utilities. The iIndustry segment secured orders amounting to Rs2,410 crore (up 37.6% YoY) during the quarter. 
  • Maintain estimates: In spite of weak order inflow, the company has maintained its robust order inflow outlook for the year, based on the strong bids in the pipeline like NTPC bulk tendering. Hence, for now we have maintained our estimate, which are already on the conservative side compared to consensus estimates. We are estimating a compounded annual growth rate (CAGR) of 13.9% in the top line and 16.1% in the adjusted earnings over FY2011-13.
  • Maintain Buy: While BHEL has one of the best business models amongst our coverage universe, given its strong revenue visibility and a robust balance sheet, we feel that there could be execution challenges from the client side. While the competition is intensifying in the private sector, order inflows from state electricity boards (SEBs) would be key for the company in achieving the Rs60,000 crore plus guidance for FY2012. Hence, unless the order inflow picks up in the next six months, we feel that there could be a severe downgrade in our as well as the Street's estimates. On the positive side the company's non- power business has done well and the company is taking initiatives to enter new areas like solar and transmission & distribution which have also started bearing fruits as reflected in Q1FY2012 results. At the current market price, the stock trades at 12.9x FY2013E earnings, which is quite attractive and at a significant discount to its historic multiple of 20-21x. Overall, we maintain our long term bullish stance on the stock and price target of Rs2,596. 
 
Maruti Suzuki India    
Cluster: Apple Green
Recommendation: Hold
Price target: Rs1,316
Current market price: Rs1,178
Price target revised to Rs1,316 
Result highlights
  • The first quarter of FY2012 saw the highest ever realisation per vehicle for Maruti Suzuki at Rs3.02 lakh. On a sequential basis, the same was up 3% on account of lower discounts and a change in the domestic product mix. The company saw the diesel mix improving from 19% in Q4FY2011 to 21% in Q1FY2012. On a year-on-year (Y-o-Y) basis, despite the discounts being higher by Rs1,200 per vehicle, the realisation increased by 4.3% YoY. The management has indicated that the discount levels are likely to increase in Q2FY2012 due to a seasonally weak quarter.
  • The contribution per vehicle improved by Rs342 on a sequential basis which is a positive sign (we were expecting a decline in the same). This was primarily on account of a better product mix in favour of diesel variants, price hikes and lower discounts (discounts are netted off from sales). 
  • Q1FY2012 also saw the other expenses declining by 21% quarter on quarter (QoQ) as against a volume decline of 18%. This was primarily on account of a lower royalty and reduced activity level. Consequently, the operating profit margin (OPM) came in at 9.5%, which was higher than our expectation. 
  • The other income for the quarter saw an incremental impact of capital gains (Rs40 crore) and a higher yield on investment. As a result, the profit after tax (PAT) was higher than expected at Rs549.2 crore, indicating an increase of 18% YoY.
  • The management indicated that most of the cost increases in the raw materials have been factored. Further, it expects the prices of steel, aluminium and rubber to moderate from Q3FY2012 onwards. Also, on the localisation front, the management intends to reduce its indirect exposure to the Japanese Yen-denominated imports through vendors. Currently the indirect yen exposure is at 15% of net sales which the management aims to bring down by 2-3% every year.
  • We have revised upwards our estimates for FY2012 (owing to the higher than expected Q1FY2012 PAT) and that for FY2013 (on account of the shift in the product mix towards the diesel segment). Consequently, our earnings per share (EPS) estimates for FY2012 and FY2013 stand at Rs93.5 and Rs109.7 respectively. Though we revise our estimates upwards, we have lowered our target multiple from 13x to 12x on account of the macro headwinds that have intensified. We maintain our Hold recommendation on the stock with a revised price target of Rs1,316.    

 
Click here to read report: Investor's Eye

Regards,
The Sharekhan Research Team
myaccount@sharekhan.com 
 www.sharekhan.com to manage your newsletter subscriptions
 


Fw: Documentary proofs to be provided while transferring fund through Demand Drafts/Pay orders/Bankers cheque in favour of India Infoline ltd.

 

Sub: Documentary proofs to be provided while transferring fund through Demand Drafts/Pay orders/Bankers cheque in favour of India Infoline ltd.

This refers to policy of IIFL on acceptance of Demand draft (DD) /Pay Order (PO)/Bankers Cheque (BC) from the clients requiring the following   
1)      Demand draft to be strictly in name of "India Infoline Ltd-(8 digits Login ID of client)'.
2)      Proof from the bank /customer from whose account the Demand draft/Pay order is drawn.
 
SEBI  vide its circular dated  June 09, 2011   has now directed that  Demand Draft, Pay Order, Banker's cheque, etc can be accepted only if the same is accompanied with the proof of the name of the bank account holder and number of the bank account debited for the purpose duly certified by the issuing bank.
 
In view of the SEBI directives and as per policy of IIFL, following needs to be ensured by clients while transferring fund in favour of India Infoline Ltd. through DDs/POs/BCs:
 
1.         All DDs/ POs/ BCs should be strictly in name of "India Infoline Ltd-Account (8 digits Login ID of client)'.
 
2.         DDs/ POs/ BCs should be accompanied with any one of the following:
 
a.    Certificate from the issuing bank on its letterhead or on a plain paper with the seal of the issuing bank.
b.    Copy of the requisition slip (portion which is retained by the bank) to issue the instrument duly certified by the Banker.
c.     Copy of the passbook/bank statement for the account debited to issue the instrument certified by the Banker.
d.    Authentication of the bank account number debited and name of the account holder by the   issuing bank on the reverse of the DD/PO/BC.
 
3.         In case the value of DDs/ POs/ BCs provided is less than Rs.50,000/- per day, any of the following additional documents can also be accepted as proof:
  
a.    Copy of the passbook/bank statement for the account debited to issue the instrument certified by the client.
b.    Demand Draft having name of the client as drawer on DD.
c.     Copy of Debit mandate letter issued by client to bank for issuing Demand Draft duly certified by the client.
d.    Copy of Bank acknowledged Transaction slip for making Demand draft by the client.
 
Further, in case DD/PO/BC provided is for an amount of Rs. 25 lacs or above, client shall additionally be required to submit a proof of source of funds used for making the DD along with the self declaration.
 
Hereafter, all Demand Drafts, Pay Orders, Bankers cheques would be accepted only if the above documents are received along with the instruments. Any demand draft received from client without the above proofs will not be accepted /credited to the client's account.
 
If you require any clarifications or assistance, you may please contact your respective Relationship Manager or write to us at cs@indiainfoline.com or reach our Customer Care Desk at (022) 40071000.
 Assuring you of our best service at all times.
 
Regards,
Customer Service
IIFL

 


Monday, July 25, 2011

Fw: IPO Update - L&T Finance Holding Ltd

 

Sharekhan IPO Mailer
ISSUE HIGHLIGHTS(SOURCE: BRLM/RHP)

ISSUE DETAILS
Issue Period: 27 July 2011 to 29 July 2011
Price Band: Rs 51 to Rs 59
Issue Size: Rs 1,245 crore
Market Lot: 100 shares and in multiples of 100
IPO Grade: 5/5 (CARE/ICRA)
L&T Finance Holdings is a financial holding company offering a diverse range of financial products and services across the corporate, retail and infrastructure finance sectors, as well as mutual fund products and investment management services, through its direct and indirect wholly owned subsidiaries. The company is registered with the Reserve Bank of India as a Systemically Important Non-Deposit Taking Non-Banking Financial Company and has applied for registration as a "core investment company".
L&T Finance is promoted by Larsen and Toubro (L&T) as part of its corporate strategy to provide a distinct identity to its financial services business. The operations of L&T Finance are classified into four business groups: the Infrastructure Finance Group, the Retail Finance Group, the Corporate Finance Group and the Investment Management Group. The company's network of offices has been established to cater to the growing business needs of its diverse customer base, which includes individual retail customers as well as large companies, banks, multinational companies and small- and medium-enterprises, and to provide them with satisfactory customer service according to their varying requirements.

Click to Invest Now or Call Dial n Trade on 1-800-22-7050 / 30307600

Alternatively you can also drop in at our nearest
Sharekhan Branch and collect the IPO forms.
Sharekhan Ltd.: BSE Cash-INB011073351; F&O-INF011073351; NSE - INB/INF231073330; MAPIN - 100008375; DP: NSDL-IN-DP-NSDL-233-2003; CDSL-IN-DP-CDSL-271-2004; PMS INP000000662. Sharekhan Commodities Pvt. Ltd.: MCX-10080; NCDEX-00132; MAPIN - 100013912, for any complaints email at igc@sharekhan.com. Regd/Admin Add:- A-206, Phoenix House, Phoenix Mills Compound, Senapati Bapat Marg, Lower Parel, Mumbai - 400013. Please carefully read the risk disclosure document as prescribed by SEBI & FMC and Do's & Don'ts by NCDEX.
Disclaimer: Investments in equity is subject to market risks. You are advised to carefully read the red herring prospectus of the company go through all the Risk Factors mentioned in the offer document issued by the fore investing. The investment as mentioned in the document may not be suitable for all investors. Investors may take their own decisions based on their specific investment objectives and financial position and using such independent advisors, as they believe necessary.


Fw: Investor's Eye: Update - RIL, Bharti Airtel, GCPL, Thermax, Bank of India, Allahabad Bank

 

Sharekhan Investor's Eye
 
Investor's Eye
[July 25, 2011]
Summary of Content
 STOCK UPDATE
Reliance Industries    
Cluster: Evergreen
Recommendation: Buy
Price target: Under review 
Current market price: Rs882
Q1FY2012 results: First-cut analysis
Result highlights
  • PAT in line with estimate, despite higher sales as margin contracted: Reliance Industries Ltd (RIL)'s earnings in Q1FY2012 have been reported at Rs5,661 crore (in line with our estimate). Though the sales were 15% higher than expected, earnings fell in line of our estimates due to the lower than anticipated margin in petrochem and upstream exploration & production (E&P) segment. The E&P margins were dented by lower production and spreads in the polyester & polymer chains were also under pressure, but the gross refining margins (GRM) were healthy at $10.3 per barrel. This is better than the GRM margin of $9.2 per barrel in Q4FY2011 and $7.3 per barrel in Q1FY2011. 
  • Impressive sales growth driven by refining segment: RIL reported net sales of Rs81,018 crore, 15% higher than our estimate. This reflects a year-on-year (Y-o-Y) growth of 39% and a quarter-on-quarter (QoQ) growth of 12%. The Y-o-Y growth was mainly driven by a 32% growth in the petrochemical segment and a stupendous 46% growth in the refining segment. Nevertheless, the revenue of the exploration & production (E&P) segment declined 17% YoY. Sequentially, sales have been primarily driven by an 18% growth in the refining division. The refining segment reported sales 24% higher than we estimated. 
  • Operating margins lower than estimated though profit marginally lower: The operating profit margin (OPM) came in 218bps lower than our estimate at 12.25%. This is a contraction of 379bps YoY and 129bps QoQ. The profit before interest and tax (PBIT) margin of the exploration & production (E&P) segment contracted by 335 basis points YoY to 37.8% in Q1FY2012, primarily on account of a 19% YoY lower gas production at 44.7 mmscmd. Moreover, the PBIT margin of the petrochemical division also contracted by 271bps YoY and 237bps QoQ to 12.06%. This is against our estimated PBIT margin of 13%. Nevertheless, the profitability in the refining segment improved marginally, both on YoY as well as QoQ basis, to 4.3% which again is better than our estimate. The operating profit of RIL in Q1FY2012 increased by 6.3% YoY and remained flat sequentially at Rs9,926, which is 2% lower than our estimate. 
  • PAT in line with our estimate due to higher other income: The profit after tax (PAT) grew 17% YoY on a 6% growth of operating profit in Q1FY2012 due to a significant (49%) improvement in other income and lower depreciation cost. On a sequential basis, the PAT grew by 5% while the operating profit remained flat due to lower interest and depreciation cost apart from higher other income. A higher other income would be attributed to a significantly higher cash balance.
  • Valuation: Currently, the RIL stock is trading at 12x and 11x its FY2012E and FY2013E earnings. It is trading at an enterprise value/earnings before interest, depreciation, tax and amortisation (EV/EBIDTA) multiple of 5x. Currently our target price is under review though we continue to have a Buy recommendation on RIL. We will release a detailed note shortly.
 
Bharti Airtel     
Cluster: Apple Green
Recommendation: Buy
Price target: Under review 
Current market price: Rs433
Continuous positive domestic data points lead us to upgrade to Buy
  • Bharti Airtel has hiked its pre-paid on-net tariff rates (Airtel to Airtel) in six circles by 20% from 1 paise per second to 1.2 paise per second. 
  • The six circles where the tariff hike has been effected are Delhi, Rajasthan, Andhra Pradesh, Gujarat, Madhya Pradesh and Uttar Pradesh (East).
  • The new tariff is effective from July 22, 2011 on new recharge by the subscribers.
  • Remain bullish on Bharti Airtel, price target under review: We maintain our bullish stance on Bharti Airtel due to an improving domestic environment, return of pricing power to the telecom players and margin levers from the African venture. Thus, we upgrade our rating on the stock from Hold to Buy. In view of the impending announcement of the Q1FY2012 results in the next week (on August 3, 2011) we keep our earnings estimate unchanged and our price target under review.
 
Godrej Consumer Products    
Cluster: Apple Green
Recommendation: Buy
Price target: Rs487
Current market price: Rs440
Price target revised to Rs487
Result highlights
  • GCPL's Q1FY2012 (consolidated) performance was a mixed bag: Godrej Consumer Products Ltd (GCPL)'s top line growth of about 40% year on year (YoY) was in line with our expectation on the back of a strong revenue growth in both the domestic and international businesses during the quarter. However, for the first time in the last ten quarters GCPL's operating profit margin (OPM) slid below 17.0% due to higher year-on-year (Y-o-Y) advertisement spends and other expenses. Hence, the adjusted profit after tax (PAT) growth decelerated to 12.9% YoY during the quarter. However, the reported PAT grew by a handsome 94.2% YoY largely on account of a post-tax one-time income of Rs136.6 crore on termination of the licence to manufacture and market the Kiwi brand in India and Sri Lanka.
  • Net sales grew by 40% YoY: In Q1FY2012 GCPL's (consolidated) net sales grew by 40% YoY to Rs997.8 crore, in line with our expectation of Rs993.4 crore. The strong top line growth was achieved on the back of a 20% year-on-year (Y-o-Y) revenue growth in the domestic business (the soap segment revenues grew by 17% YoY, the hair colour segment revenues grew by 19% YoY and the household insecticide segment revenues grew by 40% YoY) and a 93% Y-o-Y revenue growth in the international business during the quarter. The sustenance of the steady volume growth in the domestic soap and hair colour businesses and a strong growth in the domestic household insecticide business were two of the highlights of the quarter's performance. 
  • OPM stood at 14.8%: The consolidated gross margin stood flat at 51% YoY (down by 304 basis points sequentially). However, higher than anticipated employee and advertisement costs dragged the operating profit margin (OPM) by 381 basis points YoY to 14.8% (which was lower than our expectation of 17.8%). The advertisement expenses as a percentage of sales rose by 138 basis points YoY to 11.7% during the quarter. The new product launches in the domestic and international markets were supported by higher advertisement spends which inflated the advertisement expenses significantly during the quarter. Also, the other expenses, which went up by 52% YoY, affected the profitability resulting in an operating profit growth of just 10.6% YoY during the quarter. 
  • Exceptional profit boosted the bottom line growth: The adjusted profit after tax (PAT) grew by 12.9% YoY to Rs102.7 crore, which was in line with the growth in the operating profit during the quarter (lower than our expectation of Rs123.0 crore). The exceptional item of Rs175.17 crore (Rs136.6 crore post-tax) aided the reported PAT to grow by 94.2% YoY to Rs239.3 crore during the quarter. GCPL and its wholly owned subsidiary, Godrej Household Product Lanka (Pvt) Ltd, have received Rs156.19 crore and Rs18.98 crore respectively as one-time compensation for the termination of the licence to manufacture and distribute the Kiwi shoe care and Kiwi Keen brands in India and Sri Lanka.
  • Outlook and valuation: Though we have tinkered with our estimates for FY2012 to factor in the higher than expected advertisement spends, we have broadly maintained our estimates for FY2013. With the sustenance of the steady volume growth in the core (domestic) segments, such as soaps and hair colour, and the sustenance of strong growth in the international business, we expect GCPL's top line and bottom line to grow at a compounded annual growth rate (CAGR) of 18.5% and 18.0% over FY2010-12. However, the key things to watch out for in the coming quarters are the movement in the prices of the key inputs (including palm oil), the growth performance of the domestic business and the timely integration of the recent acquisitions. We value GCPL's existing business at 23x its FY2013E earnings per share (EPS) of Rs20.5. We have also assigned a value to GCPL's stake in the Darling group at Rs16 per share. Hence, our new sum-of-the-parts price target stands at Rs487, which provides an upside of 11% from the current level. We, therefore, maintain our Buy recommendation on the stock. At the current market price the stock trades at 26.0x its FY2012E EPS of Rs16.9 and 21.5x its FY2013E EPS of Rs20.5. 
 
Thermax     
Cluster: Emerging Star 
Recommendation: Hold
Price target: Rs679
Current market price: Rs610
Downgraded to Hold
Result highlights
  • Thermax' Q1FY2012 results were above our expectations on almost all fronts due to strong execution reported in the energy segment. However, margins were lower on a yearly basis on account of strong growth witnessed in revenue from the lower margin engineering procurement and construction (EPC) projects segment and higher input cost. 
  • Top line growth led by strong execution: The net income from operations increased by 32.6% year on year (YoY) led by a robust growth in energy segment revenues. The environment division reported a moderate 18% year on year (YoY) growth in sales. 
  • Operating margin under slight pressure: The company reported an operating profit margin (OPM) of 10.9%, which was lower than Q1FY2011 OPM of 12.2%. This was mainly due to higher raw material cost. Margins were also lower as the contribution from the lower margin EPC orders to the revenue increased to Rs316 crore from Rs180 crore in Q1FY2011. The profit before interest and tax (PBIT) margin in both the divisions was under pressure. 
  • Net profit grew by 20.7%: In spite of an almost nil interest charge and subdued depreciation, pressurised margins led to a lower year on-year (Y-o-Y) growth in profit after tax (PAT) by 20.7% to Rs79.9 crore.
  • Order inflow moderated, but needs to pick up: The company's current order backlog at the group level stands at Rs6,804 crore (down 3% YoY). The order inflow during the quarter stood at Rs1,688 crore (down 8% YoY). In the standalone order inflow of Rs1,444 crore, ferrous metal accounted for 35% of the order book while other sectors - textiles, cement, and sugar accounted for 22%, 12% and 4.5% of the order book respectively. The order inflow was down 17% YoY on account of one big order worth Rs580 crore getting booked in Q1FY2011. The company has indicated that a delay in finalisation of orders from the client side has resulted in subdued order inflow, particularly in the captive power segment. Moreover, if the order finalisation doesn't pick up in H2FY2012 then the company's order book growth could remain muted in FY2012. Nonetheless, the company is seeing an improving demand from the new sector - textile for captive power projects.
  • Estimates downgraded by 6-7%: In view of a muted order inflow in the last few quarters and the lull in the order awarding activities in infrastructure, we have downgraded our earnings estimates by 6-7% for FY2012 and FY2013. We now expect the company to post a compounded annual growth rate (CAGR) of 14.8% in profit over FY2011-13.We also feel that the company could aggressively bid for projects in coming times to keep its order book ringing although competition is rising. This would adversely impact its margins leading to margin pressure in the coming quarters. 
  • Price target revised to Rs679: We are particularly not enthused by the fall in order inflow in the recent few quarters. However, the company has recently forayed into new space like solar which holds a lot of potential and would help in further diversification. Today, Thermax has also announced an agreement with US based Amonix Inc, to bring proven CPV technology for clean power generation to India. In this exclusive partnership, Amonix will offer high-performance solar power generation systems and the company will be the EPC partner to provide turnkey solutions to customers in India. In line with the company's expectations, we feel that an improvement in the order awarding scenario in the next six months has become critical for building up of growth outlook from FY2013 onwards. We are downgrading our target multiple to 16x from 18x on a muted growth outlook and impending margin pressure. Accordingly, we are revising our price target to Rs679 at 16x FY2013E earning per share (EPS). At the current market price, the stock trades at 16.9x and 14.4x its FY2012 and FY2013 earnings estimates respectively. The current valuations are factoring in this muted outlook and hence we downgrade our Buy rating to Hold on the stock. We feel that the key positive triggers in the stock remain the winning of big ticket size orders, sound execution of orders and some relief on margins in view of the recent cooling off of commodity prices. 
 
Bank of India     
Cluster: Apple Green
Recommendation: Buy
Price target: Rs460 
Current market price: Rs403
Price target revised to Rs460 
Result highlights
  • Bank of India's Q1FY2012 result came in significantly below our estimates as net profits declined by 28.6% year on year (YoY) to Rs517.5 crore, led by a slower growth in net interest income (NII) and higher provisions. The NII declined by 20.2% quarter on quarter (QoQ) mainly due to the reversal of Rs175 crore of interest income. The margins reported a steep decline of 75 basis points QoQ to 2.19%. The slippages shored up during the quarter to Rs1,684 crore contributed by agriculture and restructured advances. We have reduced our estimates for FY2012 and FY2013 and target price to Rs460 (from Rs500 earlier). Currently the stock trades at 1x FY2013E book value, which is at a significant discount to its peers (Punjab National Bank [PNB], Bank of Baroda [BOB]) due to asset quality pressures. Consequently we maintain our Buy rating on the stock. 
  • Steep fall in margins: The net interest margin (NIM) registered a steep fall as it declined by 75 basis points sequentially to 2.19%. This was due to a sharp increase in the cost of funds which grew 70 basis points QoQ to 6% and contraction in yield on funds (at 7.6% compared to 7.8% in Q4FY2011). The investment yields also contracted 67 basis points QoQ to 7.4% due to investment in short term securities. Going forward, the management has guided at a NIM of 2.5% for FY2012.
  • NII impacted by reversal of interest and slower business growth: Bank of India's NII declined 20.2% QoQ and grew 5.8% YoY due to the reversal of Rs175 crore of interest income. Adjusting for the interest reversal, the NII would have grown by 15.8% YoY. The advances growth remained subdued as domestic advances declined by 2.4% QoQ.
  • Subdued growth in non interest income: The total non-interest income fell ~20% QoQ while it grew 12.7% YoY. The fee income growth remained weak as it grew 13% YoY while foreign exchange (forex) income grew 12% YoY. However the treasury profits were the key driver for non interest income as the bank booked Rs110 crore of treasury profits compared to Rs100 crore in Q1FY2011. 
  • Significant increase in slippages: In Q1FY2012 the bank reported slippages to the tune of Rs1,684 crore contributed by agriculture (Rs600 crore) and restructured accounts (Rs359 crore). The bank shifted agri accounts in excess of Rs5 lakh to system based non performing asset (NPA) recognition which contributed to a sharp rise in slippages from the agri segment. Consequently the gross and net NPAs increased to 2.69% and 1.27% respectively from 2.23% and 0.91% in Q4FY2011. The management has guided for higher NPAs in Q2FY2012 but expects recoveries to cushion the impact. We have increased loan loss provision estimates for FY2012 to factor higher provisions.
  • Capital adequacy ratio at 11.57%: The bank had a capital adequacy ratio (CAR) of 11.57% with a tier I CAR of 8.02%. Given the slower growth in profits due to high provisions, the bank would seek capital from the government to meet funding requirements. In case of delay in capital availability the advances growth could get constrained.
  • Valuations: Bank of India's Q1FY2012 results were marred by a sharp increase in slippages and a fall in margins. The core income growth slowed due to a reversal of interest income while higher provisions led by increase in slippages dented the bottom line. In order to factor slower business growth, lower margins and higher credit costs, we have reduced our estimates for FY2012 by 13% and FY2013 by 4%. We have also revised our target price to Rs460 (1.2x FY2013E book value). Currently the stock trades at 1x FY2013E book value, which is at a significant discount to its peers (PNB, BOB) due to asset quality pressures. Consequently we maintain our Buy rating on the stock.
 
Allahabad Bank     
Cluster: Cannonball
Recommendation: Buy
Price target: Rs270 
Current market price: Rs221
A strong operating performance in Q1
Result highlights
  • Allahabad Bank's Q1FY2012 results came in line with our estimates at the net interest income (NII) level while the net profit was slightly higher than our estimate-it grew by 20.4% year on year (YoY) to Rs418 crore. This was led by a strong growth in the bank's NII, which grew by 38.2% YoY due to strong growth in advances and a steady net interest margin (NIM; 3.4% compared to 3.5% in Q4FY2011). An improvement in the asset quality was another positive as the gross non-performing asset (NPA) and net NPA declined to 1.62% and 0.6% respectively (from 1.74% and 0.79% respectively in Q4FY2011). We estimate Allahabad Bank's earnings would grow at a compounded annual growth rate (CAGR) of 28.2% over FY2011-13 driven by a 18.6% growth in the NII. We maintain our Buy recommendation on the bank with a price target of Rs270 (1.4x FY2012 book value [BV]).
  • Strong growth in NII: The NII of the bank increased by a strong 38.2% YoY and 2.1% quarter on quarter (QoQ) to Rs1,175.6 crore in Q1FY2012. This was driven by a healthy growth in the advances, which grew by a 30.4% YoY, and steady margins. The deposits grew by 23.5% YoY and 1.5% sequentially whereas the current account savings account (CASA) ratio was at 32.2%. Going forward, increased deposits from the government business are likely to boost the CASA ratio.
  • Advances up 5.5% QoQ led by corporate and SME segments: The advances of the bank showed a robust growth of 30.4% YoY and 5.5% QoQ. This was led by a 13.7% sequential growth in the small and medium enterprise (SME) advances followed by a 5.5% sequential growth in the corporate advances. The bank has turned cautious towards lending to the infrastructure sector, which contributes around 21% of the book (of which 14% is to the power sector). The bank has around Rs8,000 crore exposure to the state electricity boards (SEBs) and there are no issues relating to servicing of these loans. Going forward, the management has guided for advances growth of 25% for FY2012.
  • Margins remain firm at 3.4%: Despite rising cost pressures Allahabad Bank's margin remained steady QoQ at 3.4% (compared to 3.49% in Q4FY2011) led by a growth in the high-yielding segment and repricing of the advances. The yield on loans expanded to 11.6% in Q1FY2012 from 10.7% in Q4FY2011 which cushioned the margin. The cost of funds expanded by 86 basis points QoQ to 6.86% which was offset by almost a similar growth (of 80 basis points QoQ) in the yield on funds. The management expects to maintain the margin in excess of 3% in future.
  • Steady growth in fee income: The overall non-interest income declined by 4.2% YoY to Rs286 crore mainly due to a lower treasury income. The fee income was the key driver of the non-interest income, which grew by 21.8% YoY to Rs207 crore. The treasury profits in the quarter were Rs26 crore compared to Rs90 crore in Q1FY2011. 
  • Asset quality improves: The slippages remained low during the quarter at Rs150 crore while the recoveries were higher at Rs250 crore. This led to an improvement in the asset quality as the gross and net NPAs declined to 1.62% and 0.6% respectively from 1.74% and 0.79% respectively in the earlier quarter. The bank has migrated to system-based NPA recognition for the accounts ranging from Rs50 lakh to Rs1 crore while accounts below Rs50 lakh (constituting 24% of the book) will be done in Q2FY2012. The restructured advances increased to Rs3,059 crore (3.1% of the advances) due to the restructuring of a Rs270-crore power project in Karnataka. The management has guided for a recovery of Rs10,150 crore in FY2012 which should cushion the asset quality.
  • Valuations: Allahabad Bank's Q1FY2011 performance was characterised by a strong NII growth, a decline in the NPAs and a strong fee income growth. The bank targets to grow its advances in FY2012 by 25%, which is significantly higher than the industry growth rate. Currently the stock trades at 1.2x FY2012 BV. We expect the earnings of the bank to grow at a CAGR of 28.2% over FY2011-13. The bank is likely to maintain return on equity (RoE) of 21.1% and return on assets (RoA) of 1.1% over the next two years. We maintain our Buy rating on the stock with a price target of Rs270 (1.4x FY2012 BV estimate).   

 
Click here to read report: Investor's Eye

Regards,
The Sharekhan Research Team
myaccount@sharekhan.com 
 www.sharekhan.com to manage your newsletter subscriptions